Company Profile
CEO
Ms. Ashley A. McEvoy(CEO, President & Director)
Sector
Healthcare
Industry
Medical Devices
Employees
5.4K
Beta
1.13
Forward P/E
18.9
52W High
$354.88
52W Low
$140.63
Profit Margin
10.4%
Operating Margin
16.0%
Return on Equity
23.0%
Revenue Growth
33.9%
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID al...
Valuation
Market Cap$10.49B
P/E (TTM)35.40
P/S (TTM)3.44
EV/EBITDA19.24
Cash Flow
FCF Yield+3.4%
SBC Adj. FCF Yield+2.6%
SBC Impact23.8%
Margins & Growth
Profit Margin12.0%
Operating Margin16.0%
Revenue YoY33.9%
Earnings YoY157.3%
Balance
Cash$480.40M
Debt$1.40B
Net Cash$-917.40M
Dividend
Dividend Yield--
Payout Ratio--
Quarterly Payout--